Protection against homologous influenza challenge by genetic immunization with SFV-RNA encoding Flu-HA.
SmithKline Beecham Biologicals, Rixensart, Belgium.
W
W
Dalemans
A
A
Delers
C
C
Delmelle
F
F
Denamur
R
R
Meykens
C
C
Thiriart
S
S
Veenstra
M
M
Francotte
C
C
Bruck
J
J
Cohen
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D005822:Genetic Vectors; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D006389:Hemagglutinins, Viral / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D007117:Immunization, Secondary; D009980:Influenza A virus / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000276:immunology; D007273:Injections, Intramuscular; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000276:immunology / Q000517:prevention & control*; D012313:RNA / Q000235:genetics*; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000276:immunology*; D012137:Respiratory System / Q000821:virology; D014611:Vaccination; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology
D000914:Antibodies, Viral; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D006389:Hemagglutinins, Viral; D007252:Influenza Vaccines; C039919:RNA, recombinant; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic; D012313:RNA